Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-2917. 10.1002/ijc.25516.
Article
CAS
PubMed
Google Scholar
Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT: An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 2008, 68: 6084-6091. 10.1158/0008-5472.CAN-07-6854.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008, 8: 187-198. 10.2174/156800908784293659.
Article
CAS
PubMed
Google Scholar
Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem. 2001, 70: 535-602. 10.1146/annurev.biochem.70.1.535.
Article
CAS
PubMed
Google Scholar
Cantley LC: The phosphoinositide 3-kinase pathway. Science. 2002, 296: 1655-1657. 10.1126/science.296.5573.1655.
Article
CAS
PubMed
Google Scholar
Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2: 489-501. 10.1038/nrc839.
Article
CAS
PubMed
Google Scholar
Zhao L, Vogt PK: Class I PI3K in oncogenic cellular transformation. Oncogene. 2008, 27: 5486-5496. 10.1038/onc.2008.244.
Article
CAS
PubMed
PubMed Central
Google Scholar
Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK: The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A. 1998, 95: 13513-13518. 10.1073/pnas.95.23.13513.
Article
CAS
PubMed
PubMed Central
Google Scholar
Workman P, Clarke PA, Raynaud FI, van Montfort RL: Drugging the PI3 kinome: from chemical tools to drugs in the clinic. Cancer Res. 2010, 70: 2146-2157. 10.1158/0008-5472.CAN-09-4355.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science. 1991, 253: 49-53. 10.1126/science.1905840.
Article
CAS
PubMed
Google Scholar
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005, 4: 988-1004. 10.1038/nrd1902.
Article
CAS
PubMed
Google Scholar
Courtney KD, Corcoran RB, Engelman JA: The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010, 28: 1075-1083. 10.1200/JCO.2009.25.3641.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bader AG, Kang S, Zhao L, Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005, 5: 921-929. 10.1038/nrc1753.
Article
CAS
PubMed
Google Scholar
Furuyama T, Nakazawa T, Nakano I, Mori N: Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J. 2000, 349: 629-634. 10.1042/0264-6021:3490629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xuan Z, Zhang MQ: From worm to human: bioinformatics approaches to identify FOXO target genes. Mech Ageing Dev. 2005, 126: 209-215. 10.1016/j.mad.2004.09.021.
Article
CAS
PubMed
Google Scholar
Zanella F, Link W, Carnero A: Understanding FOXO, new views on old transcription factors. Curr Cancer Drug Targets. 2010, 10: 135-146. 10.2174/156800910791054158.
Article
CAS
PubMed
Google Scholar
Link W, Oyarzabal J, Serelde BG, Albarran MI, Rabal O, Cebria A, Alfonso P, Fominaya J, Renner O, Peregrina S, Soilán D, Ceballos PA, Hernández AI, Lorenzo M, Pevarello P, Granda TG, Kurz G, Carnero A, Bischoff JR: Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases. J Biol Chem. 2009, 284: 28392-28400. 10.1074/jbc.M109.038984.
Article
CAS
PubMed
PubMed Central
Google Scholar
ProQinase GmbH, Freiburg, Germany [http://www.proquinase.com]
The R Project for Statistical Computing [http://www.r-project.org/]
Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19: 185-193. 10.1093/bioinformatics/19.2.185.
Article
CAS
PubMed
Google Scholar
Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article3.,
Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, Borstein D, Peleg S, Assa S, Karp M, Benjamini Y, Hochberg Y, Laron Z: Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses. 1995, 45: 486-490. 10.1016/0306-9877(95)90228-7.
Article
CAS
PubMed
Google Scholar
Kalathur RK, Hernandez-Prieto MA, Futschik ME: Huntington’s disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database. BMC Neurol. 2012, 12: 47-10.1186/1471-2377-12-47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005, 102: 15545-15550. 10.1073/pnas.0506580102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S: AmiGO: online access to ontology and annotation data. Bioinformatics. 2009, 25: 288-289. 10.1093/bioinformatics/btn615.
Article
CAS
PubMed
Google Scholar
Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M: Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014, 42: D199-D205. 10.1093/nar/gkt1076.
Article
CAS
PubMed
Google Scholar
Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP: Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011, 27: 1739-1740. 10.1093/bioinformatics/btr260.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hill R, Madureira PA, Waisman DM, Lee PW: DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget. 2011, 2: 1094-1108.
Article
PubMed
PubMed Central
Google Scholar
Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008, 3: 1101-1108. 10.1038/nprot.2008.73.
Article
CAS
PubMed
Google Scholar
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001, 46: 3-26. 10.1016/S0169-409X(00)00129-0.
Article
CAS
PubMed
Google Scholar
Zanella F, Dos Santos NR, Link W: Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-kappaB (NF-kappaB) nuclear translocation. Traffic. 2013, 14: 247-258. 10.1111/tra.12034.
Article
CAS
PubMed
Google Scholar
Mayo LD, Donner DB: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A. 2001, 98: 11598-11603. 10.1073/pnas.181181198.
Article
CAS
PubMed
PubMed Central
Google Scholar
Basu S, Totty NF, Irwin MS, Sudol M, Downward J: Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell. 2003, 11: 11-23. 10.1016/S1097-2765(02)00776-1.
Article
CAS
PubMed
Google Scholar
Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999, 401: 86-90. 10.1038/43474.
Article
CAS
PubMed
Google Scholar
Grimes CA, Jope RS: CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001, 78: 1219-1232. 10.1046/j.1471-4159.2001.00495.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Du K, Montminy M: CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem. 1998, 273: 32377-32379. 10.1074/jbc.273.49.32377.
Article
CAS
PubMed
Google Scholar
Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR: Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene. 1994, 9: 59-70.
CAS
PubMed
Google Scholar
Lutterbach B, Hann SR: Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol. 1994, 14: 5510-5522.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, Hunter T: Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 1991, 64: 573-584. 10.1016/0092-8674(91)90241-P.
Article
CAS
PubMed
Google Scholar
Eijkelenboom A, Mokry M, De WE, Smits LM, Polderman PE, Van Triest MH, Van BR, Schulze A, De LW, Cuppen E, Burgering BM: Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling. Mol Syst Biol. 2013, 9: 638-10.1038/msb.2012.74.
Article
PubMed
PubMed Central
Google Scholar
Greer EL, Brunet A: FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005, 24: 7410-7425. 10.1038/sj.onc.1209086.
Article
CAS
PubMed
Google Scholar
Terragni J, Graham JR, Adams KW, Schaffer ME, Tullai JW, Cooper GM: Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors. BMC Cell Biol. 2008, 9: 6-10.1186/1471-2121-9-6.
Article
PubMed
PubMed Central
Google Scholar
Geng T, Li P, Yin X, Yan Z: PGC-1alpha promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice. Am J Pathol. 2011, 178: 1738-1748. 10.1016/j.ajpath.2011.01.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC: Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol. 2004, 24: 2181-2189. 10.1128/MCB.24.5.2181-2189.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arden KC: FoxO: linking new signaling pathways. Mol Cell. 2004, 14: 416-418. 10.1016/S1097-2765(04)00213-8.
Article
CAS
PubMed
Google Scholar
Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004, 117: 421-426. 10.1016/S0092-8674(04)00452-0.
Article
CAS
PubMed
Google Scholar
Tinkum KL, White LS, Marpegan L, Herzog E, Piwnica-Worms D, Piwnica-Worms H: Forkhead box O1 (FOXO1) protein, but not p53, contributes to robust induction of p21 expression in fasted mice. J Biol Chem. 2013, 288: 27999-28008. 10.1074/jbc.M113.494328.
Article
CAS
PubMed
PubMed Central
Google Scholar
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE: High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004, 304: 554-10.1126/science.1096502.
Article
CAS
PubMed
Google Scholar
Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA: Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 2004, 64: 7678-7681. 10.1158/0008-5472.CAN-04-2933.
Article
CAS
PubMed
Google Scholar
Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH: The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther. 2004, 3: 772-775. 10.4161/cbt.3.8.994.
Article
CAS
PubMed
Google Scholar
Collins I, Workman P: New approaches to molecular cancer therapeutics. Nat Chem Biol. 2006, 2: 689-700. 10.1038/nchembio840.
Article
CAS
PubMed
Google Scholar
O’Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, Baselga J, Rosen N: mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006, 66: 1500-1508. 10.1158/0008-5472.CAN-05-2925.
Article
PubMed
PubMed Central
Google Scholar
Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, Barnett J, Leslie NR, Cheng S, Shepherd PR, Gout I, Downes CP, Lamb RF: The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol. 2004, 166: 213-223. 10.1083/jcb.200403069.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carracedo A, Pandolfi PP: The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008, 27: 5527-5541. 10.1038/onc.2008.247.
Article
CAS
PubMed
Google Scholar
Raynaud FI, Eccles S, Clarke PA, Hayes A, Nutley B, Alix S, Henley A, Di-Stefano F, Ahmad Z, Guillard S, Guillard S, Bjerke LM, Kelland L, Valenti M, Patterson L, Gowan S, De Haven BA, Hayakawa M, Kaizawa H, Koizumi T, Ohishi T, Patel S, Saghir N, Parker P, Waterfield M, Workman P: Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 2007, 67: 5840-5850. 10.1158/0008-5472.CAN-06-4615.
Article
CAS
PubMed
Google Scholar
Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerod A, Karesen R, Oh DS, Dressler LG, Lonning PE, Strausberg RL, Chanock S, Borresen-Dale AL, Perou CM: Mutation of GATA3 in human breast tumors. Oncogene. 2004, 23: 7669-7678. 10.1038/sj.onc.1207966.
Article
CAS
PubMed
Google Scholar
Guillard S, Clarke PA, Te PR, Mohri Z, Bjerke L, Valenti M, Raynaud F, Eccles SA, Workman P: Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma. Cell Cycle. 2009, 8: 443-453. 10.4161/cc.8.3.7643.
Article
CAS
PubMed
Google Scholar
van der Vos KE, Coffer PJ: The extending network of FOXO transcriptional target genes. Antioxid Redox Signal. 2011, 14: 579-592. 10.1089/ars.2010.3419.
Article
CAS
PubMed
Google Scholar
Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolfi S, Fernandez Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Cajal S, Schwartz S, Vivancos A, Espin E, Rojas S, Baselga J, Tabernero J, Munoz A, Palmer HG: Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med. 2012, 18: 892-901. 10.1038/nm.2772.
Article
CAS
PubMed
Google Scholar
Rosso M, Lapyckyj L, Amiano N, Besso MJ, Sanchez M, Chuluyan E, Vazquez-Levin MH: Secretory leukocyte protease inhibitor (SLPI) expression downregulates E-cadherin, induces beta-catenin re-localisation and triggers apoptosis-related events in breast cancer cells. Biol Cell. 2014, 106: 308-322. 10.1111/boc.201300075.
Article
CAS
PubMed
Google Scholar
Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH: Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol. 2002, 22: 7842-7852. 10.1128/MCB.22.22.7842-7852.2002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baranwal S, Wang Y, Rathinam R, Lee J, Jin L, McGoey R, Pylayeva Y, Giancotti F, Blobe GC, Alahari SK: Molecular characterization of the tumor-suppressive function of nischarin in breast cancer. J Natl Cancer Inst. 2011, 103: 1513-1528. 10.1093/jnci/djr350.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hill R, Cautain B, De PN, Link W: Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget. 2014, 5: 11-28.
Article
PubMed
Google Scholar